According to the Prosecutorial Daily on December 5th, Chen, from Yancheng, Jiangsu, had his probation revoked for using the Schedule II psychotropic drug, ethylphenidate. He was sentenced to one year imprisonment to carry out the original sentence.
In September, Mr. Chen purchased four electronic pods containing ethylmethylphenidate through WeChat. Considering he was on probation and hesitant to consume them, he kept the electronic pods hidden at home. On October 1st, the National Medical Products Administration, Ministry of Public Security, and National Health Commission officially included ethylmethylphenidate in the second category of psychotropic drugs. Consequently, Mr. Chen wanted to dispose of these electronic pods as soon as possible.
On the early morning of October 7th, Chen secretly consumed a portion of ethylmethylphenidate electronic pod, thinking he could get away with it. However, he was caught by the police and subsequently detained for 10 days. On October 11th, the Judicial Bureau of Tinghu District proposed to revoke Chen's probation to the Binhai County Court, and the relevant documents were transferred to the Procuratorate of Tinghu District. The Procuratorate conducted an investigation and verification, and after reviewing the case, concluded that Chen's actions met the conditions for revoking probation. They agreed with the proposal from the Judicial Bureau of Tinghu District to revoke Chen's probation.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
